Skip to main content

Advertisement

Log in

Antiretroviral Therapy Concealment Behaviors and their Association with Antiretroviral Therapy Adherence among People with HIV: Findings from the Florida Cohort Study

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Little is known about HIV medication concealment behaviors and the effect of medication concealment on antiretroviral therapy (ART) adherence among people with HIV (PWH). This study aims to (1) to describe medication concealment behaviors and factors associated with these behaviors, and (2) assess the association between medication concealment and suboptimal ART adherence. The Florida Cohort Study enrolled adult PWH from community-based clinics around the state from October 2020 to September 2022 (n = 416, 62% aged 50+, 56% male, 44% non-Hispanic Black, 18% Hispanic). Participants responded to questions about sociodemographics, stigma, ART adherence (≥ 85%), symptoms of depression, social networks and disclosure to their networks, and actions to conceal ART to avoid inadvertent disclosure of their HIV status. Analyses were conducted using multivariable logistic regressions models. The most common concealment behavior was hiding ART while having guests over (32%), followed by removing ART labels (26%), and putting ART into a different bottle (16%). Overall, 43% reported ≥ 1 behavior. In multivariable models, depressive symptoms, incomplete disclosure of HIV to close social networks, and not having a close social network were associated with ART concealment. After adjusting for risk factors for suboptimal ART adherence, endorsing hiding medication while having guests was associated with suboptimal ART adherence (aOR 2.87, 95% CI 1.15–7.55). Taking any action and other individual behaviors were not associated. ART concealment behaviors were common but did not consistently negatively influence adherence when accounting for other factors. PWH may want to receive ART medications in ways that ensure privacy and reduce the risk of inadvertent disclosure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data and Code Availability

The data used in this study can be requested from the Southern HIV and Alcohol Research Consortium (https://sharc-research.org/research/data/sharc-concepts-system/) and the code can be provided by the corresponding author upon request.

References

  1. Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: a plan for the United States. JAMA. 2019;321:844–5.

    Article  PubMed  Google Scholar 

  2. CDC. HIV in the United States by Region. : HIV Diagnoses [Internet]. Cent. Dis. Control Prev. 2022 [cited 2022 Dec 11]. Available from: https://www.cdc.gov/hiv/statistics/overview/diagnoses.html.

  3. Mannheimer SB, Matts J, Telzak E, Chesney M, Child C, Wu AW, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005;17:10–22.

    Article  CAS  PubMed  Google Scholar 

  4. Gordon LL, Gharibian D, Chong K, Chun H. Comparison of HIV Virologic failure Rates between patients with variable adherence to three antiretroviral regimen types. AIDS Patient Care STDs. 2015;29:384–8.

    Article  PubMed  Google Scholar 

  5. Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and Virologic failure: a Meta-analysis. Med (Baltim). 2016;95:e3361.

    Article  CAS  Google Scholar 

  6. Byrd KK, Hou JG, Hazen R, Kirkham H, Suzuki S, Clay PG et al. Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data. J Acquir Immune Defic Syndr 1999. 2019;82:245–51.

  7. Centers for Disease Control and Prevention. HIV Transmission [Internet]. HIV Basics. 2020 [cited 2022 Dec 14]. Available from: https://www.cdc.gov/hiv/basics/transmission.html.

  8. Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321:451–2.

    Article  PubMed  Google Scholar 

  9. Harrigan PR, Hogg RS, Dong WWY, Yip B, Wynhoven B, Woodward J, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191:339–47.

    Article  CAS  PubMed  Google Scholar 

  10. Prosperi M, Veras N, Azarian T, Rathore M, Nolan D, Rand K et al. Molecular Epidemiology of Community-Associated Methicillin-resistant Staphylococcus aureus in the genomic era: a Cross-Sectional Study. Sci Rep [Internet]. 2013 [cited 2020 Nov 14];3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664956/.

  11. Benson C, Wang X, Dunn KJ, Li N, Mesana L, Lai J, et al. Antiretroviral adherence, Drug Resistance, and the impact of Social Determinants of Health in HIV-1 patients in the US. AIDS Behav. 2020;24:3562–73.

    Article  CAS  PubMed  Google Scholar 

  12. Blackard JT, Mayer KH. HIV superinfection in the era of increased sexual risk-taking. Sex Transm Dis. 2004;31:201–4.

    Article  PubMed  Google Scholar 

  13. Rich SN, Poschman K, Hu H, Mavian C, Cook RL, Salemi M et al. Sociodemographic, Ecological, and Spatiotemporal Factors Associated with Human Immunodeficiency Virus Drug Resistance in Florida: A Retrospective Analysis. J Infect Dis [Internet]. 2020 [cited 2020 Nov 14]; Available from: https://academic.oup.com/jid/advance-article/doi/https://doi.org/10.1093/infdis/jiaa413/5869388.

  14. McComsey GA, Lingohr-Smith M, Rogers R, Lin J, Donga P. Real-world adherence to antiretroviral therapy among HIV-1 Patients across the United States. Adv Ther. 2021;38:4961–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Viral Suppression | HIV in the United States by Region | Statistics Overview. | Statistics Center | HIV/AIDS | CDC [Internet]. [cited 2023 Mar 7]. Available from: https://www.cdc.gov/hiv/statistics/overview/viral-suppression.html.

  16. Centers for Disease Control and Prevention. HIV in the United States by Region: Viral Suppression [Internet]. Cent. Dis. Control Prev. 2022 [cited 2023 Jan 15]. Available from: https://www.cdc.gov/hiv/statistics/overview/viral-suppression.html.

  17. Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsdóttir TB, Richter C, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med. 2014;12:142.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Friedman MR, Stall R, Silvestre AJ, Wei C, Shoptaw S, Herrick A, et al. Effects of syndemics on HIV viral load and medication adherence in the multicentre AIDS cohort study. AIDS. 2015;29:1087.

    Article  PubMed  Google Scholar 

  19. Simoni JM, Huh D, Wilson IB, Shen J, Goggin K, Reynolds NR et al. Racial/Ethnic Disparities in ART Adherence in the United States: Findings From the MACH14 Study. J Acquir Immune Defic Syndr 1999. 2012;60:466–72.

  20. Ghidei L, Simone M, Salow M, Zimmerman K, Paquin AM, Skarf LM, et al. Aging, Antiretrovirals, and adherence: a Meta analysis of adherence among older HIV-Infected individuals. Drugs Aging. 2013;30. https://doi.org/10.1007/s40266-013-0107-7.

  21. Puskas CM, Forrest JI, Parashar S, Salters KA, Cescon AM, Kaida A, et al. Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Curr HIV/AIDS Rep. 2011;8:277–87.

    Article  PubMed  Google Scholar 

  22. Rueda S, Mitra S, Chen S, Gogolishvili D, Globerman J, Chambers L, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016;6:e011453.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Sweeney SM, Vanable PA. The Association of HIV-Related Stigma to HIV Medication Adherence: a systematic review and synthesis of the literature. AIDS Behav. 2016;20:29–50.

    Article  PubMed  Google Scholar 

  24. Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D, et al. The role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence. AIDS Behav. 2006;10:483–93.

    Article  PubMed  Google Scholar 

  25. Pichon LC, Rossi KR, Ogg SA, Krull LJ, Griffin DY. Social Support, Stigma and Disclosure: examining the relationship with HIV Medication Adherence among Ryan White Program clients in the Mid-South USA. Int J Environ Res Public Health. 2015;12:7073–84.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Izudi J, Okoboi S, Lwevola P, Kadengye D, Bajunirwe F. Effect of disclosure of HIV status on patient representation and adherence to clinic visits in eastern Uganda: a propensity-score matched analysis. PLoS ONE. 2021;16:e0258745.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Dessie G, Wagnew F, Mulugeta H, Amare D, Jara D, Leshargie CT, et al. The effect of disclosure on adherence to antiretroviral therapy among adults living with HIV in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2019;19:528.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Tegegne AS, Ndlovu P, Zewotir T. Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot teaching and Specialized Hospital, north-western Ethiopia; a prospective study. BMC Infect Dis. 2018;18:83.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Reda AA, Biadgilign S, Deribe K, Deribew A. HIV-positive status disclosure among men and women receiving antiretroviral treatment in eastern Ethiopia. AIDS Care. 2013;25:956–60.

    Article  PubMed  Google Scholar 

  30. Penot P, Héma A, Bado G, Sombié D, Kaboré FN, Poda A, et al. Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship. AIDS Care. 2018;30:1502–6.

    Article  PubMed  Google Scholar 

  31. Rintamaki L, Kosenko K, Hogan T, Scott AM, Dobmeier C, Tingue E, et al. The role of Stigma Management in HIV Treatment Adherence. Int J Environ Res Public Health. 2019;16:5003.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Rao D, Kekwaletswe TC, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19:28–33.

    Article  CAS  PubMed  Google Scholar 

  33. Singh G, Pauranik A, Menon B, Paul BS, Selai C, Chowdhury D, et al. The dilemma of arranged marriages in people with epilepsy. An expert group appraisal. Epilepsy Behav. 2016;61:242–7.

    Article  PubMed  Google Scholar 

  34. Nishio I, Chujo M. Self-stigma of patients with type 1 diabetes and their coping strategies. Yonago Acta Med. 2017;60:167–73.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Calabrese SK, Martin S, Wolters PL, Toledo-Tamula MA, Brennan TL, Wood LV. Diagnosis disclosure, medication hiding, and medical functioning among perinatally-infected, HIV-positive children and adolescents. AIDS Care. 2012;24:1092–6.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Rotzinger A, Locatelli I, Reymermier M, Amico S, Bugnon O, Cavassini M, et al. Association of disclosure of HIV status with medication adherence. Patient Educ Couns. 2016;99:1413–20.

    Article  PubMed  Google Scholar 

  37. Madiba S, Josiah U. Perceived Stigma and Fear of Unintended Disclosure are Barriers in Medication Adherence in Adolescents with Perinatal HIV in Botswana: a qualitative study. BioMed Res Int. 2019;2019:e9623159.

    Article  Google Scholar 

  38. Ibañez GE, Zhou Z, Cook CL, Slade TA, Somboonwit C, Morano J, et al. The Florida Cohort study: methodology, initial findings and lessons learned from a multisite cohort of people living with HIV in Florida. AIDS Care. 2021;33:516–24.

    Article  PubMed  Google Scholar 

  39. USDA ERS - Rural-. Urban Commuting Area Codes [Internet]. [cited 2023 Jan 31]. Available from: https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes/.

  40. Rural Urban Commuting. Area Codes Data [Internet]. [cited 2023 Jan 31]. Available from: https://depts.washington.edu/uwruca/ruca-uses.php.

  41. O’Halloran Leach E, Lu H, Caballero J, Thomas JE, Spencer EC, Cook RL. Defining the optimal cut-point of self-reported ART adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study. AIDS Res Ther. 2021;18:36.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT: The alcohol use disorders identification test: Guidelines for use in primary health care [Internet]. 2nd ed. Geneva, Switzerland: World Health Organization; 2001. Available from: https://apps.who.int/iris/handle/10665/67205.

  43. Saunders JB, Aasland OG, Babor TF, De La Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol Consumption-II. Addiction. 1993;88:791–804.

    Article  CAS  PubMed  Google Scholar 

  44. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA, for the Ambulatory Care Quality Improvement Project (ACQUIP). The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for Problem drinking. Arch Intern Med. 1998;158:1789–95.

    Article  CAS  PubMed  Google Scholar 

  45. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7.

    Article  PubMed  Google Scholar 

  46. Kroenke K, Strine TW, Spitzer RL, Williams JBW, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114:163–73.

    Article  PubMed  Google Scholar 

  47. Mayer M, missRanger. Fast Imputation of Missing Values [Internet]. 2021 [cited 2023 Jan 31]. Available from: https://CRAN.R-project.org/package=missRanger.

  48. Stekhoven DJ, Bühlmann P. MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28:112–8.

    Article  CAS  PubMed  Google Scholar 

  49. Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and Meta-analysis. PLoS Med. 2016;13:e1002183.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Sheinfil AZ, Foley JD, Moskal D, Dalton MR, Firkey M, Ramos J, et al. Daily Associations between Alcohol Consumption and antiretroviral therapy (ART) adherence among HIV-Positive men who have sex with men. AIDS Behav. 2022;26:3153–63.

    Article  PubMed  Google Scholar 

  51. Braithwaite RS, Bryant KJ. Influence of Alcohol Consumption on Adherence to and toxicity of antiretroviral therapy and survival. Alcohol Res Health. 2010;33:280–7.

    PubMed  PubMed Central  Google Scholar 

  52. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21:2409–19.

    Article  PubMed  Google Scholar 

  53. Heinze G, Ploner M, Dunkler D, Southworth H, Jiricka L. logistf: Firth’s Bias-Reduced Logistic Regression [Internet]. 2022 [cited 2023 Mar 7]. Available from: https://CRAN.R-project.org/package=logistf.

  54. Imai K, Keele L, Yamamoto T, Identification. Inference and sensitivity analysis for Causal Mediation Effects. Stat Sci. 2010;25:51–71.

    Article  MathSciNet  Google Scholar 

  55. Tingley D, Yamamoto T, Hirose K, Keele L, Imai K, Trinh M et al. mediation: Causal Mediation Analysis [Internet]. 2019 [cited 2023 Aug 7]. Available from: https://cran.r-project.org/web/packages/mediation/index.html.

  56. Ramadhani HO, Muiruri C, Maro VP, Nyombi B, Omondi M, Mushi JB, et al. Patient-initiated repackaging of antiretroviral therapy, viral suppression and drug resistance. AIDS Behav. 2018;22:1671–8.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Battles HB, Wiener LS. From adolescence through young adulthood: psychosocial adjustment associated with long-term survival of HIV. J Adolesc Health. 2002;30:161–8.

    Article  PubMed  Google Scholar 

  58. Damulira C, Mukasa MN, Byansi W, Nabunya P, Kivumbi A, Namatovu P, et al. Examining the relationship of social support and family cohesion on ART adherence among HIV-positive adolescents in southern Uganda: baseline findings. Vulnerable Child Youth Stud. 2019;14:181–90.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Bilardi JE, Hulme-Chambers A, Chen MY, Fairley CK, Huffam SE, Tomnay JE. The role of stigma in the acceptance and disclosure of HIV among recently diagnosed men who have sex with men in Australia: a qualitative study. PLoS ONE. 2019;14:e0224616.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Mahajan AP, Sayles JN, Patel VA, Remien RH, Ortiz D, Szekeres G, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS Lond Engl. 2008;22:67–79.

    Article  Google Scholar 

  61. Logie CH, Sokolovic N, Kazemi M, Islam S, Frank P, Gormley R, et al. Does resource insecurity drive HIV-related stigma? Associations between food and housing insecurity with HIV-related stigma in cohort of women living with HIV in Canada. J Int AIDS Soc. 2022;25:e25913.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Gielen AC, Ghandour RM, Burke JG, Mahoney P, McDonnell KA, O’Campo P. HIV/AIDS and intimate Partner violence: intersecting women’s Health Issues in the United States. Trauma Violence Abuse. 2007;8:178–98.

    Article  PubMed  Google Scholar 

  63. Koren DE, Fedkiv V, Zhao H, Kludjian G, Bettiker RL, Tedaldi E, et al. Perceptions of long-acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center. J Int Assoc Provid AIDS Care. 2020;19:2325958220981265.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Beima-SofieKristin MS, ChristodoulouJoan HM, TapiaKenneth MG et al. Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV. AIDS Patient Care STDs [Internet]. 2019 [cited 2023 Jan 15]; Available from: https://www.liebertpub.com/doi/https://doi.org/10.1089/apc.2018.0198.

  65. Simoni JM, Beima-Sofie K, Wanje G, Mohamed ZH, Tapia K, McClelland RS, et al. Lighten this Burden of Ours: acceptability and preferences regarding injectable antiretroviral treatment among adults and Youth Living with HIV in Coastal Kenya. J Int Assoc Provid AIDS Care. 2021;20:23259582211000516.

    Article  Google Scholar 

  66. Rice WS, Turan B, Fletcher FE, Nápoles TM, Walcott M, Batchelder A, et al. A mixed methods study of anticipated and experienced stigma in Health Care Settings among Women living with HIV in the United States. AIDS Patient Care STDs. 2019;33:184–95.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Dapaah JM, Senah KA. HIV/AIDS clients, privacy and confidentiality; the case of two health centres in the Ashanti Region of Ghana. BMC Med Ethics. 2016;17:41.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Kane JC, Elafros MA, Murray SM, Mitchell EMH, Augustinavicius JL, Causevic S, et al. A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries. BMC Med. 2019;17:17.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Fonner VA, Geurkink D, Chiwanga F, Amiri I, Likindikoki S. Long-Distance Travel for HIV-Related Care—Burden or Choice? A mixed methods study in Tanzania. AIDS Behav. 2021;25:2071–83.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Andersson GZ, Reinius M, Eriksson LE, Svedhem V, Esfahani FM, Deuba K, et al. Stigma reduction interventions in people living with HIV to improve health-related quality of life. Lancet HIV. 2020;7:e129–40.

    Article  PubMed  Google Scholar 

  71. Leddy AM, Weiss E, Yam E, Pulerwitz J. Gender-based violence and engagement in biomedical HIV prevention, care and treatment: a scoping review. BMC Public Health. 2019;19:897.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Smith R, Villanueva G, Probyn K, Sguassero Y, Ford N, Orrell C, et al. Accuracy of measures for antiretroviral adherence in people living with HIV. Cochrane Database Syst Rev. 2022;7:CD013080.

    PubMed  Google Scholar 

  73. Woodward EN, Pantalone DW. The role of Social Support and negative affect in Medication Adherence for HIV-infected men who have sex with men. J Assoc Nurses AIDS Care JANAC. 2012;23:388–96.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Zhigang Li and Seungjun Ahn for their advice on the statistical analyses. We would also like to thank the Florida Cohort coordination and recruitment team, especially Edwige Nicholas, and the study participants.

Funding

This work was supported by the National Institute on Alcohol Abuse and Alcoholism (grants T32AA025877, F31AA030518, U24AA022002).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: Fisk-Hoffman, Parisi, Siuluta, Ding, Cook; Methodology & Formal Analysis: Fisk-Hoffman; Writing-Original Draft: Fisk-Hoffman, Parisi, Siuluta, Ding; Writing-Review & Editing: Fisk-Hoffman, Parisi, Siuluta, Ding, Widmeyer, Somboonwit, Cook; Supervision: Cook.

Corresponding author

Correspondence to Robert L. Cook.

Ethics declarations

Ethics Approval

The Florida Cohort Study was reviewed by the Institutional Review Board at the University of Florida (IRB#201,801,680). This study adheres to the tenets of the Declaration of Helsinki.

Informed Consent

All participants provided written informed consent prior to participation.

Financial and Non-Financial Interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fisk-Hoffman, R.J., Parisi, C.E., Siuluta, N. et al. Antiretroviral Therapy Concealment Behaviors and their Association with Antiretroviral Therapy Adherence among People with HIV: Findings from the Florida Cohort Study. AIDS Behav 28, 1047–1057 (2024). https://doi.org/10.1007/s10461-023-04214-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-023-04214-w

Keywords

Navigation